Letter from the Editors

Editorial Office

doi:10.36013/jrdod.v2i.33

Abstract

Last year we successfully introduced a new journal: The Journal of Rare Diseases and Orphan Drugs (JRDOD) is a peer-reviewed open-access medical journal that publishes original research, reviews, case reports, and letters covering a broad field of its specialty. We intend to publish articles stimulating to read, educate, and inform readers with the most up-to-date research in genetics, rare diseases, and new orphan drug development in different stages of clinical trials. Journal topics are centered on patients living with undiagnosed rare diseases, the importance of a diagnosis, individual approaches to treatments. We hope that this journal will increase awareness of many difficult to diagnosed and treat medical conditions.

Highlights

Dear Readers, Authors, Reviewer, and Friends: Last year we successfully introduced a new journal: The Journal of Rare Diseases and Orphan Drugs (JRDOD) is a peerreviewed open-access medical journal that publishes original research, reviews, case reports, and letters covering a broad field of its specialty
The mission of our journal is to facilitate the development of awareness about rare disease conditions among medical professionals; provide educational support for the medical community, patients, and families focused on rare disease conditions; support research focused on prevention and treatment for the benefit of patients with rare disorders; distribute transformative therapies using platform technology that can be deployed across multiple rare diseases
After the 1983 Orphan Drug Act in the United States, more than 420 orphan drugs and biologic products for rare diseases have been approved by the Food and Drug Administration (FDA), compared with fewer than ten such products in the decade before the Act [1,2]

Summary

Introduction

Dear Readers, Authors, Reviewer, and Friends: Last year we successfully introduced a new journal: The Journal of Rare Diseases and Orphan Drugs (JRDOD) is a peerreviewed open-access medical journal that publishes original research, reviews, case reports, and letters covering a broad field of its specialty. We intend to publish articles stimulating to read, educate, and inform readers with the most up-to-date research in genetics, rare diseases, and new orphan drug development in different stages of clinical trials. Journal topics are centered on patients living with undiagnosed rare diseases, the importance of a diagnosis, individual approaches to treatments.

Results

Conclusion